Back to today’s briefing

Story perspectives

Animal Biotechnology Market Projected to Reach $48.68 Billion

1/18/2025

45 8

Summary

Biotech Market Soars

The Animal Biotechnology market is set to soar from $30.33 billion in 2024 to an impressive $48.68 billion by 2029. This surge is fueled by breakthroughs in vaccine development and a rising focus on animal health. With industry giants like Zoetis and Merck at the forefront, North America dominates, while Asia-Pacific emerges as the fastest-growing region.

Summary

Pet Diagnostics Surge

The companion animal diagnostic services market is set to soar to $13.95 billion by 2030, fueled by a 7.51% annual growth rate. Innovations in diagnostics, a surge in pet insurance, and heightened health awareness are driving this trend. North America currently dominates, while Asia-Pacific is poised for rapid expansion. Notably, dogs are the most commonly diagnosed pets.

History

Historical Context

The booming animal biotechnology market mirrors the 2000s biotech surge, driven by technological advancements. Companies like Zoetis and Merck, akin to early biotech leaders, capitalize on innovations in health and diagnostics. This growth reflects a historical trend of increasing investment in animal health, paralleling human health advancements.

1 of 3

Biotech Market Soars

The Animal Biotechnology market is set to soar from $30.33 billion in 2024 to an impressive $48.68 billion by 2029. This surge is fueled by breakthroughs in vaccine development and a rising focus on animal health. With industry giants like Zoetis and Merck at the forefront, North America dominates, while Asia-Pacific emerges as the fastest-growing region.

1 / 3